FBIO
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Fortress Biotech and Cyprium announce FDA acceptance of CUTX-101 NDA resubmissionDec 15, 2025
- Fortress Biotech and subsidiary Urica Therapeutics announce first patients dosed in Crystalys Therapeutics' global Phase 3 trials of Dotinurad for treatment of goutOct 21, 2025
- Fortress Biotech and Cyprium Therapeutics announce update on NDA for CUTX-101Oct 1, 2025
- Sun Pharma to acquire Checkpoint TherapeuticsMar 11, 2025
- Sun Pharma to acquire Checkpoint TherapeuticsMar 11, 2025